Clinical Trial Update: Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of different rosuvastatin doses on LDL cholesterol and liver/muscle safety markers (AST and CPK) in individuals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (Crestor) (rosuvastatin)

Snippet

Sponsor: Central Park Medical College | Conditions: LDL - Low Density Lipoprotein Receptor Disorder, Rosuvastatin | NA | Status: COMPLETED